- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about CCXI
Recent news which mentions CCXI
3 Biotech Stocks That Could Double in 2022
January 03, 2022
From Motley Fool
Big Pharma Is Going Holiday Shopping. Who's Next?
November 10, 2021
From Motley Fool
ChemoCentryx, inc (CCXI) Q3 2021 Earnings Call Transcript
November 10, 2021
Tickers
CCXI
From Motley Fool
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
From Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
From Benzinga
Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates
November 02, 2021
From Benzinga
From Motley Fool
2 Super-Charged Growth Stocks to Buy Now
October 13, 2021
From Motley Fool
45 Biggest Movers From Yesterday
October 13, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2021
October 11, 2021
From Benzinga
Thinking About Buying Stock In Starbucks, Peloton Or ChemoCentryx?
October 11, 2021
From Benzinga
10 Biggest Price Target Changes For Monday
October 11, 2021
From Benzinga
A Peek Into The Markets: US Stock Futures Down; Crude Oil Jumps 2%
October 11, 2021
From Benzinga
35 Biggest Movers From Friday
October 11, 2021
From Benzinga
5 Stocks To Watch For October 11, 2021
October 11, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage
October 10, 2021
From Benzinga
Mid-Afternoon Market Update: Dow Surges 80 Points; ChemoCentryx Shares Spike Higher
October 08, 2021
From Benzinga
From Motley Fool
12 Health Care Stocks Moving In Friday's Intraday Session
October 08, 2021
From Benzinga
From Benzinga
EXCLUSIVE: ChemoCentryx Plans To Start Phase 3 Avacopan Trial In Chronic Skin Disorder In 2022
October 08, 2021
Tickers
CCXI
From Benzinga
28 Stocks Moving In Friday's Mid-Day Session
October 08, 2021
From Benzinga
Tickers
CCXI
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.